Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 113 articles:
HTML format



Single Articles


    December 2023
  1. LEI W, Wen Y, Yang Y, Liu S, et al
    Chlamydia trachomatis T3SS effector CT622 induces proinflammatory cytokines through TLR2/TLR4-mediated MAPKs/NF-kappaB pathways in THP-1 cells.
    J Infect Dis. 2023 Dec 26:jiad597. doi: 10.1093.
    PubMed     Abstract available


  2. TEDIJANTO C, Aragie S, Gwyn S, Wittberg DM, et al
    Seroreversion to Chlamydia trachomatis Pgp3 antigen among children in a hyperendemic region of Amhara, Ethiopia.
    J Infect Dis. 2023 Dec 22:jiad602. doi: 10.1093.
    PubMed     Abstract available


  3. DIONNE JA, Giacani L, Tamhane A, Workowski K, et al
    Prevalence and Predictors of Oral Treponema pallidum Detection by qPCR in Early Syphilis.
    J Infect Dis. 2023 Dec 21:jiad582. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  4. GIULIANO AR, Palefsky JM, Goldstone SE, Dubin B, et al
    High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.
    J Infect Dis. 2023 Nov 28:jiad485. doi: 10.1093.
    PubMed     Abstract available


  5. MORRILL SR, Saha S, Varki AP, Lewis WG, et al
    Gardnerella Vaginolysin Potentiates Glycan Molecular Mimicry by Neisseria gonorrhoeae.
    J Infect Dis. 2023;228:1610-1620.
    PubMed     Abstract available


  6. SKARGA E, Surcel HM, Kaaks R, Waterboer T, et al
    Sexually Transmitted Infections and Risk of Epithelial Ovarian Cancer: Results From the Finnish Maternity Cohort.
    J Infect Dis. 2023;228:1621-1629.
    PubMed     Abstract available


  7. PHILLIPS LT, Witney AA, Furegato M, Laing KG, et al
    Time Required for Nanopore Whole-Genome Sequencing of Neisseria gonorrhoeae for Identification of Phylogenetic Relationships.
    J Infect Dis. 2023;228:1179-1188.
    PubMed     Abstract available


    October 2023
  8. KUSTERS JMA, Brouwer JGM, van Benthem BHB, Heijne JCM, et al
    Global Type-Specific Genital Human Papillomavirus Prevalence in Men, by Sexual Orientation: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2023;228:1023-1032.
    PubMed     Abstract available


  9. HALL CDX, Ryan D, Hayford C, Morgan E, et al
    Syphilis Prevalence, Incidence, and Demographic Differences in a Longitudinal Study of Young Sexual and Gender Minority Adults Assigned Male at Birth.
    J Infect Dis. 2023 Oct 10:jiad256. doi: 10.1093.
    PubMed     Abstract available


  10. FENG E, Monteiro JK, Portillo AL, Balint E, et al
    Natural Killer Cell-Derived Interferon-gamma Regulates Macrophage-Mediated Immunopathology During Viral Infection.
    J Infect Dis. 2023;228:834-839.
    PubMed     Abstract available


    September 2023
  11. LIEBERMAN NAP, Avendano CC, Bakhash SAKM, Nunley E, et al
    Genomic Epidemiology of Treponema pallidum and Circulation of Strains With Diminished tprK Antigen Variation Capability in Seattle, 2021-2022.
    J Infect Dis. 2023 Sep 28:jiad368. doi: 10.1093.
    PubMed     Abstract available


    August 2023
  12. AL-SONEIDAR WA, Harper S, Coutlee F, Gheit T, et al
    Prevalence of Alpha, Beta, and Gamma Human Papillomaviruses (HPV) in head and neck cancer patients and non-cancer controls and relation to behavioral factors.
    J Infect Dis. 2023 Aug 16:jiad335. doi: 10.1093.
    PubMed     Abstract available


  13. CLARK JL, Oldenburg CE, Passaro RC, Segura ER, et al
    Changes in Inflammatory Cytokine Levels in Rectal Mucosa Associated with Neisseria Gonorrheae and/or Chlamydia trachomatis Infection and Treatment Among Men Who Have Sex with Men in Lima, Peru.
    J Infect Dis. 2023 Aug 16:jiad349. doi: 10.1093.
    PubMed     Abstract available


  14. MALAGON T, Trottier H, El-Zein M, Villa LL, et al
    Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women.
    J Infect Dis. 2023;228:402-411.
    PubMed     Abstract available


  15. SUOMINEN NT, Luukkaala TH, Laprise C, Haataja MA, et al
    Human papillomavirus concordance between parents and their newborn offspring: Results from the Finnish Family HPV study.
    J Infect Dis. 2023 Aug 10:jiad330. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  16. LI X, Ling Y, Hu L, Zhang L, et al
    Detection of HPV DNA, E6/E7 mRNA, and p16INK4a in lung cancer: A systematic review and meta-analysis.
    J Infect Dis. 2023 Jul 28:jiad295. doi: 10.1093.
    PubMed     Abstract available


  17. TANG Y, Liu X, Chen W, Luo X, et al
    Antimicrobial Resistance Profiling and Genome Analysis of the penA-60.001 Neisseria gonorrhoeae Clinical Isolates in China in 2021.
    J Infect Dis. 2023 Jul 18:jiad258. doi: 10.1093.
    PubMed     Abstract available


  18. BRAMBLE JAT, Pepperell CS
    Making sense of the past: Columbus and the European syphilis epidemic.
    J Infect Dis. 2023 Jul 13:jiad249. doi: 10.1093.
    PubMed    


  19. OUMAROU HAMA H, Boualam MA, Levasseur A, Ardagna Y, et al
    Old World medieval Treponema pallidum complex treponematosis: a case report.
    J Infect Dis. 2023 Jul 13:jiad248. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  20. FERREIRA MT, Mendoza Lopez RV, Goncalves MG, Ferreira S, et al
    HPV-16 lineage A variants are associated with persistent genital infections in men: The HIM Study.
    J Infect Dis. 2023 Jun 4:jiad204. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  21. WEI F, Alberts CJ, Albuquerque A, Clifford GM, et al
    Impact of human papillomavirus vaccine against anal human papillomavirus infection, anal intraepithelial neoplasia, and recurrence of anal intraepithelial neoplasia: a systematic review and meta-analysis.
    J Infect Dis. 2023 May 31:jiad183. doi: 10.1093.
    PubMed     Abstract available


  22. MORAIS S, Wissing MD, Khosrow-Khavar F, Burchell AN, et al
    Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study.
    J Infect Dis. 2023;227:1173-1184.
    PubMed     Abstract available


  23. JORDAN SJ, Wilson L, Ren J, Gupta K, et al
    Natural clearance of Chlamydia trachomatis infection is associated with distinct differences in cervicovaginal metabolites.
    J Infect Dis. 2023 May 11:jiad155. doi: 10.1093.
    PubMed     Abstract available


  24. LIN HY, Fu Q, Tseng TS, Zhu X, et al
    Impact of Dietary Quality on Genital Oncogenic HPV Infection in Women.
    J Infect Dis. 2023 May 10:jiad146. doi: 10.1093.
    PubMed     Abstract available


  25. BROWN SE, Tuddenham S, Shardell MD, Klebanoff MA, et al
    Bacterial vaginosis and spontaneous clearance of Chlamydia trachomatis in the Longitudinal Study of Vaginal Flora.
    J Infect Dis. 2023 May 9:jiad142. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  26. WHITTLES LK, Galiwango RM, Mpagazi J, Tobian AAR, et al
    Age patterns of HSV-2 incidence and prevalence in two Ugandan communities: a catalytic incidence model applied to population-based seroprevalence data.
    J Infect Dis. 2023 Apr 20:jiad113. doi: 10.1093.
    PubMed     Abstract available


  27. CLIFFORD GM, Wei F
    Prevention of Human Papillomavirus-Related Anal Cancer in Women Living With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:929-931.
    PubMed    


  28. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    PubMed     Abstract available


  29. BRISTOW CC, Mortimer TD, Morris S, Grad YH, et al
    Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae.
    J Infect Dis. 2023;227:917-925.
    PubMed     Abstract available


    March 2023
  30. VAN EER K, Middeldorp M, Dzebisasjvili T, Lamkaraf N, et al
    Effects of two and three vaccinations with the bivalent HPV vaccine on the prevalence and load of HPV in clearing and persistent infections in young women.
    J Infect Dis. 2023 Mar 29:jiad080. doi: 10.1093.
    PubMed     Abstract available


  31. LUO Y, Wang C, Du Z, Wang C, et al
    NO-producing Polymorphonuclear Neutrophils Confer Protection against Chlamydia psittaci in Mouse Lung Infection.
    J Infect Dis. 2023 Mar 24:jiad072. doi: 10.1093.
    PubMed     Abstract available


  32. WHITE JL, Grabowski MK, Rositch AF, Gravitt PE, et al
    Trends in adolescent human papillomavirus vaccination and parental hesitancy in the United States.
    J Infect Dis. 2023 Mar 3:jiad055. doi: 10.1093.
    PubMed     Abstract available


    February 2023
  33. LI Y, You S, Lee K, Yaesoubi R, et al
    The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018.
    J Infect Dis. 2023 Feb 18:jiad047. doi: 10.1093.
    PubMed     Abstract available


  34. BROTHWELL JA, Fortney KR, Batteiger T, Katz BP, et al
    Dispensability of Ascorbic Acid Uptake and Utilization Encoded by ulaABCD for the Virulence of Haemophilus ducreyi in Humans.
    J Infect Dis. 2023;227:317-321.
    PubMed     Abstract available


    January 2023
  35. CHAMBERS C, Deeks SL, Sutradhar R, Cox J, et al
    Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men.
    J Infect Dis. 2023 Jan 19:jiad005. doi: 10.1093.
    PubMed     Abstract available


  36. PHILLIPS S, Cornall AM, Molano M, Jin F, et al
    Performance of human papillomavirus (HPV) attribution algorithms to predict causative genotypes in anal high-grade lesions.
    J Infect Dis. 2023 Jan 2:jiac503. doi: 10.1093.
    PubMed     Abstract available


  37. SCHWAB NR, Young NE, Nzenwata DU, Toh E, et al
    Characterization of virulence-associated traits in Mycoplasma penetrans strains acting as likely etiological agents of idiopathic non-gonococcal urethritis.
    J Infect Dis. 2023 Jan 2:jiac505. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  38. LI Z, Winer RL, Ba S, Sy MP, et al
    Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance among Women in Senegal, West Africa.
    J Infect Dis. 2022 Oct 31. pii: 6782258. doi: 10.1093.
    PubMed     Abstract available


  39. SU X, Le W, Zhu X, Li S, et al
    Neisseria gonorrhoeae infection in women increases with rising numbers of gonococci in partners: Chlamydia coinfection in women increases gonococcal burden.
    J Infect Dis. 2022 Oct 6. pii: 6750085. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  40. SHAPIRO SB, Wissing MD, Khosrow-Khavar F, El-Zein M, et al
    Male Circumcision and Genital Human Papillomavirus (HPV) Infection in Males and Their Female Sexual Partners: Findings From the HPV Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study.
    J Infect Dis. 2022;226:1184-1194.
    PubMed     Abstract available


  41. AMORRORTU RP, Zhao Y, Fenske NA, Cherpelis BS, et al
    Natural History of Incident and Persistent Cutaneous Human Papillomavirus and Human Polyomavirus Infections.
    J Infect Dis. 2022;226:1162-1174.
    PubMed     Abstract available


  42. ANDRADE PESSOA MORALES J, Marconi C, El-Zein M, Ravel J, et al
    Vaginal Microbiome Components as Correlates of Cervical Human Papillomavirus Infection.
    J Infect Dis. 2022;226:1084-1097.
    PubMed     Abstract available


  43. MEHTA SD, Nandi D, Agingu W, Green SJ, et al
    Vaginal and Penile Microbiome Associations With Herpes Simplex Virus Type 2 in Women and Their Male Sex Partners.
    J Infect Dis. 2022;226:644-654.
    PubMed     Abstract available


    July 2022
  44. BABALOLA CM, Siebert JC, Kallapur SG, Maecker HT, et al
    Discrete Plasma Cytokine Profiles among Pregnant Women in Botswana by Chlamydia trachomatis infection, HIV status, and Gestational age.
    J Infect Dis. 2022 Jul 25. pii: 6649668. doi: 10.1093.
    PubMed    


    June 2022
  45. HUNIDZARIRA P, Brown ER, Chirenje ZM, Hillier SL, et al
    Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials.
    J Infect Dis. 2022 Jun 28. pii: 6619245. doi: 10.1093.
    PubMed     Abstract available


  46. DICKEY BL, Giuliano AR, Sirak B, Abrahamsen M, et al
    Control of Epstein-Barr virus (EBV) in the oral cavity is associated with persistence of oral HPV 16/18 among men from the HPV Infection in Men (HIM) Study.
    J Infect Dis. 2022 Jun 9. pii: 6604966. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  47. MUHR LSA, Eklund C, Lagheden C, Eriksson T, et al
    Head-to-head comparison of bi- and nonavalent human papillomavirus vaccine-induced antibody responses.
    J Infect Dis. 2022 May 10. pii: 6582940. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  48. WEI F, Xia N, Ocampo R, Goodman MT, et al
    Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies.
    J Infect Dis. 2022 Mar 23. pii: 6553063. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  49. BELSHE RB, Blevins TP, Yu Y, Nethington AE, et al
    Neutralizing Antibody Kinetics and Immune Protection Against HSV-1 Genital Disease in Vaccinated Women.
    J Infect Dis. 2022 Feb 24. pii: 6535411. doi: 10.1093.
    PubMed     Abstract available


  50. JOHNSON RM, Asashima H, Mohanty S, Shaw AC, et al
    Combining cellular immunology with RNAseq to identify novel chlamydia T cell subset signatures.
    J Infect Dis. 2022 Feb 16. pii: 6529704. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  51. LAURIE C, El-Zein M, Tota J, Khosrow-Khavar F, et al
    Efficacy of a carrageenan gel in increasing clearance of anal HPV infections in men: interim analysis of a double-blind randomized controlled trial.
    J Infect Dis. 2022 Jan 28. pii: 6516990. doi: 10.1093.
    PubMed     Abstract available


  52. ZHANG Y, D'Souza G, Fakhry C, Bigelow EO, et al
    Oral HPV associated with differences in oral microbiota beta diversity and microbiota abundance.
    J Infect Dis. 2022 Jan 17. pii: 6509880. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  53. LEWIS LA, Gulati S, Zelek WM, Morgan BP, et al
    Efficacy of an experimental gonococcal lipooligosaccharide mimitope vaccine requires terminal complement.
    J Infect Dis. 2021 Dec 31. pii: 6491069. doi: 10.1093.
    PubMed     Abstract available


  54. BRUNHAM RC
    Problems with Understanding Chlamydia trachomatis Immunology.
    J Infect Dis. 2021 Dec 17. pii: 6469012. doi: 10.1093.
    PubMed     Abstract available


  55. HUI BB, Padeniya TN, Rebuli N, Gray RT, et al
    A gonococcal vaccine has the potential to rapidly reduce the incidence of Neisseria gonorrhoeae infection among urban men who have sex with men.
    J Infect Dis. 2021 Dec 11. pii: 6459455. doi: 10.1093.
    PubMed     Abstract available


  56. CHRISTENSEN H, Vickerman P
    Gonococcal vaccines for controlling Neisseria gonorrhoeae in men who have sex with men: a promising game-changer.
    J Infect Dis. 2021 Dec 11. pii: 6459454. doi: 10.1093.
    PubMed    


    October 2021
  57. LIU C, Hufnagel K, O'Connell CM, Goonetilleke N, et al
    Reduced Endometrial Ascension and Enhanced Reinfection Associated with IgG Antibodies to Specific Chlamydia trachomatis Proteins in Women at Risk for Chlamydia.
    J Infect Dis. 2021 Oct 5. pii: 6381657. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  58. MARKOWITZ LE, Schiller JT
    Human Papillomavirus Vaccines.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  59. MATTHIAS KA, Connolly KL, Begum AA, Jerse AE, et al
    Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.
    J Infect Dis. 2021 Sep 8. pii: 6366578. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  60. RAHMAN KS, Kaltenboeck B
    Multipeptide Assays for Sensitive and Differential Detection of Anti-Chlamydia Trachomatis Antibodies.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  61. PAAVONEN J, Turzanski Fortner R, Lehtinen M, Idahl A, et al
    Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  62. DARVILLE T
    Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  63. XU SX, Gray-Owen SD
    Gonococcal Pelvic Inflammatory Disease: Placing Mechanistic Insights Into the Context of Clinical and Epidemiological Observations.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  64. HORNER PJ, Flanagan H, Horne AW
    Is There a Hidden Burden of Disease as a Result of Epigenetic Epithelial-to-Mesenchymal Transition Following Chlamydia trachomatis Genital Tract Infection?
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  65. ZHENG X, Zhong W, O'Connell CM, Liu Y, et al
    Host Genetic Risk Factors for Chlamydia trachomatis-Related Infertility in Women.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  66. CONNOLLY KL, Pilligua-Lucas M, Gomez C, Costenoble-Caherty AC, et al
    Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  67. MITCHELL CM, Anyalechi GE, Cohen CR, Haggerty CL, et al
    Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  68. NAGARAJAN UM, Cho C, Gyorke CE, Nagarajan S, et al
    Tumor Necrosis Factor Alpha-Induced Interleukin-1 Alpha Synthesis and Cell Death Is Increased in Mouse Epithelial Cells Infected With Chlamydia muridarum.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  69. HORNER PJ, Anyalechi GE, Geisler WM
    What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  70. RUSSELL MW
    Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  71. HILLIER SL, Bernstein KT, Aral S
    A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  72. DAVIS GS, Horner PJ, Price MJ, Mitchell HD, et al
    What Do Diagnoses of Pelvic Inflammatory Disease in Specialist Sexual Health Services in England Tell Us About Chlamydia Control?
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  73. MAN I, Vanska S, Lehtinen M, Bogaards JA, et al
    Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
    J Infect Dis. 2021;224:481-491.
    PubMed     Abstract available


    July 2021
  74. WINER RL, Lin J, Querec TD, Unger ER, et al
    Effectiveness Of Human Papillomavirus (HPV) Vaccination Against Penile Hpv Infection In Men Who Have Sex With Men And Transgender Women.
    J Infect Dis. 2021 Jul 28. pii: 6329629. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  75. VAHLE K, Gargano JW, Lewis RM, Querec TD, et al
    Prevalence of human papillomavirus among females older than recommended age for vaccination by birth cohort, United States 20032016.
    J Infect Dis. 2021 Jun 23. pii: 6308446. doi: 10.1093.
    PubMed     Abstract available


  76. BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
    Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
    J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  77. RAVINDRAN J, Richardson B, Kinuthia J, Unger JA, et al
    Chlamydia, gonorrhea, and incident HIV infection during pregnancy predict preterm birth despite treatment.
    J Infect Dis. 2021 May 23. pii: 6282455. doi: 10.1093.
    PubMed     Abstract available


  78. SUNDSTROM K, Dillner J
    How Many Human Papillomavirus Types Do We Need to Screen For?
    J Infect Dis. 2021;223:1510-1511.
    PubMed    


  79. HOES J, King AJ, Schurink-van 't Klooster TM, Berkhof PJ, et al
    Vaccine effectiveness following routine immunization with bivalent HPV vaccine: Protection against incident genital HPV infections from a reduced-dosing schedule.
    J Infect Dis. 2021 May 8. pii: 6272563. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  80. PAUL P, Hammer A, Rositch AF, Burke AE, et al
    Rates of New Human Papillomavirus Detection and Loss of Detection in Middle-aged Women by Recent and Past Sexual Behavior.
    J Infect Dis. 2021;223:1423-1432.
    PubMed     Abstract available


  81. CUSTER J, Patel R, Delclos GL, DeSantis SM, et al
    Concurrent and Concordant Oral and Genital High-Risk Human Papillomavirus in the United States: Results from the National Health and Nutrition Examination Survey.
    J Infect Dis. 2021;223:1400-1409.
    PubMed     Abstract available


  82. KENYON C
    Dual azithromycin/ceftriaxone therapy for gonorrhoea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold.
    J Infect Dis. 2021 Apr 2. pii: 6209316. doi: 10.1093.
    PubMed    


    March 2021
  83. LIN HY, Fu Q, Kao YH, Tseng TS, et al
    Antioxidants Associated with Oncogenic HPV Infection in women.
    J Infect Dis. 2021 Mar 18. pii: 6178356. doi: 10.1093.
    PubMed     Abstract available


  84. WANG K, Dropulic L, Bozekowski J, Pietz HL, et al
    Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine.
    J Infect Dis. 2021 Mar 15. pii: 6170962. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  85. BANHART S, Selb R, Oehlmann S, Bender J, et al
    The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018.
    J Infect Dis. 2021 Feb 16. pii: 6138844. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  86. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    PubMed     Abstract available


  87. GAISA MM, Sigel KM, Deshmukh AA, Lenskaya V, et al
    Comparing Anal Cancer Screening Algorithms Using Cytology and HPV DNA Testing in Three High-risk Populations.
    J Infect Dis. 2021 Jan 3. pii: 6060069. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  88. SIERRA MS, Tsang SH, Hu S, Porras C, et al
    Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT).
    J Infect Dis. 2020 Dec 16. pii: 6039229. doi: 10.1093.
    PubMed     Abstract available


  89. EL-ZEIN M, Khosrow-Khavar F, Burchell AN, Tellier PP, et al
    Association of serum 25-hydroxyvitamin D with prevalence, incidence, and clearance of vaginal HPV infection in young women.
    J Infect Dis. 2020 Dec 11. pii: 6030992. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  90. POYNTEN IM, Jin F, Garland SM, Hillman RJ, et al
    HIV, immune dysfunction and the natural history of anal high-risk human papillomavirus infection in gay and bisexual men.
    J Infect Dis. 2020 Nov 21. pii: 5998258. doi: 10.1093.
    PubMed     Abstract available


  91. YAN Y, Zhang H, Jiang C, Ma X, et al
    Human papillomavirus prevalence and integration status in tissue samples of bladder cancer in Chinese population.
    J Infect Dis. 2020 Nov 18. pii: 5986718. doi: 10.1093.
    PubMed     Abstract available


  92. TROJA C, Hoofnagle AN, Szpiro A, Stern JE, et al
    Understanding the role of emerging vitamin D biomarkers on short-term persistence of high-risk HPV infection among mid-adult women.
    J Infect Dis. 2020 Nov 17. pii: 5986719. doi: 10.1093.
    PubMed     Abstract available


  93. LAAKE I, Feiring B, Jonassen CM, Pettersson JH, et al
    Concurrent infection with multiple human papillomavirus types among unvaccinated and vaccinated 17-year-old Norwegian girls.
    J Infect Dis. 2020 Nov 17. pii: 5986714. doi: 10.1093.
    PubMed     Abstract available


  94. GAO L, Wang Z, van der Veen S
    Gonococcal adaptation to palmitic acid through farAB expression and FadD activity mutations increases in vivo fitness in a murine genital tract infection model.
    J Infect Dis. 2020 Nov 10. pii: 5973518. doi: 10.1093.
    PubMed     Abstract available


  95. KAHLER CM
    The Goldilocks Zone: Searching for a Phylogenetic Approach for the Recombinogenic Neisseria gonorrhoeae.
    J Infect Dis. 2020;222:1762-1763.
    PubMed    


  96. CEHOVIN A, Jolley KA, Maiden MCJ, Harrison OB, et al
    Association of Neisseria gonorrhoeae Plasmids With Distinct Lineages and The Economic Status of Their Country of Origin.
    J Infect Dis. 2020;222:1826-1836.
    PubMed     Abstract available


  97. BETTAMPADI D, Dickey B, Abrahamsen M, Sirak B, et al
    Differences in factors associated with high and low risk oral HPV genotypes in men.
    J Infect Dis. 2020 Nov 5. pii: 5957070. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  98. PICKERING H, Chernet A, Sata E, Zerihun M, et al
    Genomics of Ocular Chlamydia trachomatis after 5 years of SAFE interventions for trachoma in Amhara, Ethiopia.
    J Infect Dis. 2020 Oct 9. pii: 5920008. doi: 10.1093.
    PubMed     Abstract available


  99. KANN H, Lehtinen M, Eriksson T, Surcel HM, et al
    Sustained Cross-Reactive Antibody Responses After Human Papillomavirus Vaccinations: Up To 12 Years Follow-Up In The Finnish Maternity Cohort.
    J Infect Dis. 2020 Oct 3. pii: 5917504. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  100. MEITES E, Winer RL, Newcomb ME, Gorbach PM, et al
    Vaccine effectiveness on DNA prevalence of human papillomavirus infection in anal and oral specimens from men who have sex with men- United States, 2016-2018.
    J Infect Dis. 2020 Jun 6. pii: 5854104. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  101. CLIFFORD GM, Combes JD
    Hopes for Prevention of Anal Cancer in Women.
    J Infect Dis. 2020;221:1210-1212.
    PubMed    


  102. DE SANJOSE S, Bruni L
    Is it now the time to plan for global gender-neutral vaccination?
    J Infect Dis. 2020 Mar 11. pii: 5803244. doi: 10.1093.
    PubMed    


  103. VANSKA S, Luostarinen T, Bausssano I, Apter D, et al
    Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied.
    J Infect Dis. 2020 Mar 11. pii: 5803245. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  104. DENG X, Klausner JD
    Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.
    J Infect Dis. 2020;221:851-852.
    PubMed    


  105. THOMAS JC, Kersh EN, Gernert KM, Shafer WM, et al
    Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
    J Infect Dis. 2020;221:852-853.
    PubMed    


    January 2020
  106. JOHNSON RM, Olivares-Strank N, Peng G
    A class II-restricted CD813 T cell clone protects during Chlamydia muridarum genital tract infection.
    J Infect Dis. 2020 Jan 3. pii: 5695851. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  107. KARUNAKARAN KP, Yu H, Jiang X, Chan QWT, et al
    Discordance in the epithelial cell-dendritic cell MHC class II immunoproteome: implications for Chlamydia vaccine development.
    J Infect Dis. 2019 Oct 10. pii: 5585005. doi: 10.1093.
    PubMed     Abstract available


  108. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    PubMed    


    September 2019
  109. PATEL P, Bush T, Conley L, Unger ER, et al
    Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
    J Infect Dis. 2019 Sep 19. pii: 5571724. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  110. WOESTENBERG PJ, King AJ, Van Benthem BHB, Leussink S, et al
    Bivalent Vaccine Effectiveness Against Anal Human Papillomavirus Positivity Among Female Sexually Transmitted Infection Clinic Visitors in the Netherlands.
    J Infect Dis. 2019 Apr 23. pii: 5476422. doi: 10.1093.
    PubMed     Abstract available


  111. OLESEN SW, Grad YH
    Deciphering the impact of bystander selection for antibiotic resistance in Neisseria gonorrhoeae.
    J Infect Dis. 2019 Apr 8. pii: 5430789. doi: 10.1093.
    PubMed    


  112. KENYON C, Buyze J, Spiteri G, Cole MJ, et al
    Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
    J Infect Dis. 2019 Apr 8. pii: 5430759. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  113. MULLICK C, Murray J
    Correlations between HIV infection and rectal gonorrhea incidence in men who have sex with men: Implications for future HIV pre-exposure prophylaxis trials.
    J Infect Dis. 2019 Jan 31. pii: 5304966. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.